The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).
| dc.contributor.author | Sackeim, Harold A | |
| dc.contributor.author | Aaronson, Scott T | |
| dc.contributor.author | Bunker, Mark T | |
| dc.contributor.author | Conway, Charles R | |
| dc.contributor.author | Demitrack, Mark A | |
| dc.contributor.author | George, Mark S | |
| dc.contributor.author | Prudic, Joan | |
| dc.contributor.author | Thase, Michael E | |
| dc.contributor.author | Rush, A John | |
| dc.date.accessioned | 2022-04-13T23:34:01Z | |
| dc.date.available | 2022-04-13T23:34:01Z | |
| dc.date.issued | 2019-06 | |
| dc.date.updated | 2022-04-13T23:34:00Z | |
| dc.description.abstract | There is considerable diversity in how treatment-resistant depression (TRD) is defined. However, every definition incorporates the concept that patients with TRD have not benefited sufficiently from one or more adequate trials of antidepressant treatment. This review examines the issues fundamental to the systematic evaluation of antidepressant treatment adequacy and resistance. These issues include the domains of interventions deemed effective in treatment of major depressive episodes (e.g., pharmacotherapy, brain stimulation, and psychotherapy), the subgroups of patients for whom distinct adequacy criteria are needed (e.g., bipolar vs. unipolar depression, psychotic vs. nonpsychotic depression), whether trials should be rated dichotomously as adequate or inadequate or on a potency continuum, whether combination and augmentation strategies require specific consideration, and the criteria used to evaluate the adequacy of treatment delivery (e.g., dose, duration), trial adherence, and clinical outcome. This review also presents the Antidepressant Treatment History Form: Short-Form (ATHF-SF), a completely revised version of an earlier instrument, and details how these fundamental issues were addressed in the ATHF-SF. | |
| dc.identifier | S0022-3956(18)31466-3 | |
| dc.identifier.issn | 0022-3956 | |
| dc.identifier.issn | 1879-1379 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | Journal of psychiatric research | |
| dc.relation.isversionof | 10.1016/j.jpsychires.2019.03.021 | |
| dc.subject | Humans | |
| dc.subject | Antidepressive Agents | |
| dc.subject | Treatment Outcome | |
| dc.subject | Deep Brain Stimulation | |
| dc.subject | Psychotherapy | |
| dc.subject | Depressive Disorder, Treatment-Resistant | |
| dc.subject | Surveys and Questionnaires | |
| dc.title | The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). | |
| dc.type | Journal article | |
| duke.contributor.orcid | Rush, A John|0000-0003-2004-2382 | |
| pubs.begin-page | 125 | |
| pubs.end-page | 136 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.publication-status | Published | |
| pubs.volume | 113 |
Files
Original bundle
- Name:
- Sackeim_Rush-2019_The assessment of resistance to antidepressant treatment- Rationale for the Antidepressant Treatment History Form- Short Form (ATHF-SF).pdf
- Size:
- 498.92 KB
- Format:
- Adobe Portable Document Format